135420-40-5 Suppliers

Recommended suppliersmore

135420-40-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 135420-40-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,4,2 and 0 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 135420-40:
(8*1)+(7*3)+(6*5)+(5*4)+(4*2)+(3*0)+(2*4)+(1*0)=95
95 % 10 = 5
So 135420-40-5 is a valid CAS Registry Number.

135420-40-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name	N'-[2-(diethylamino)ethyl]-4-propoxybenzenecarboximidamide,hydrochloride

1.2 Other means of identification

Product number	-
Other names	N-(2-(Diethylamino)ethyl)-4-propoxybenzenecarboximidamide hydrochloride,hydrate (2:2:1)

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:135420-40-5 SDS

135420-40-5Upstream product

135420-40-5Downstream Products

135420-40-5Relevant articles and documents

Synthesis of N1-substituted benzamidines. Effects on blood coagulation, platelet aggregation and antiarrhythmic activity.

Ferroni,Simoni,Manfredini,Guarneri,Orlandini,Barbieri,Franze,Mugelli

, p. 665 - 669 (2007/10/02)

A series of N1-substituted-4-alkoxybenzamidines was synthesized and tested in vitro for their inhibitory effects on blood coagulation and agonist induced platelet aggregation. The antiarrhythmic activity against chloroform-induced arrhythmias in mice was also evaluated. The biological activity of the title compounds is reported in comparison with that of procainamide; among the new products described, IVi and IVe were found to have the most potent anti-platelet and antiarrhythmic activity, respectively. The structure-activity relationships are discussed.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 135420-40-5

CAS

135420-40-5